Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade

Immune-checkpoint blockade in front-line or second-line treatment improves survival in advanced non-small cell lung cancer (aNSCLC) when compared with chemotherapy alone. However, easily applicable predictive parameters are necessary to guide immune-checkpoint inhibition in clinical practice. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Lang, David, Westphal, Theresa, Gampenrieder, Simon Peter, Hutarew, Georg, Weiss, Lukas, Hackl, Hubert, Lamprecht, Bernd, Rinnerthaler, Gabriel, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678702/
https://www.ncbi.nlm.nih.gov/pubmed/31295966
http://dx.doi.org/10.3390/jcm8071014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678702/
https://www.ncbi.nlm.nih.gov/pubmed/31295966
http://dx.doi.org/10.3390/jcm8071014

Ejemplares similares